医汇集团(08161.HK)预期中期亏损净额同比收窄

Group 1 - The company expects to report a net loss of no more than HKD 31,000 for the six-month period ending September 30, 2025, significantly reduced from a net loss of approximately HKD 916,000 in the same period of 2024 [1] - The reduction in loss is primarily due to the completion of the sale of a loss-making subsidiary, Hengquan Limited, in February 2025, which led to a decrease in operating losses for the reporting period [1] - Effective cost control measures implemented during the reporting period also contributed to the reduction in losses [1]